Decision Instrument · Regulatory Governance · Directed at Insurer Leadership
Insurance Authority RBC Transition Readiness Gate
A 25-question diagnostic for CFOs, CROs, Chief Actuaries, and Board Risk Committees. Evaluates whether your health insurance organisation is analytically and operationally positioned to absorb the January 2027 Risk-Based Capital mandate without a capital, governance, or pricing crisis during the 2026 pilot phase.
5 domains
25 questions
Approximately 15 minutes
Insurer leadership version
Self-assessment version. This instrument is available as a facilitated Full Diagnostic: with independent capital gap analysis, governance mapping, and a board-ready Proceed / Delay / Redesign recommendation specific to your RBC transition context.
Section 1 of 5: Capital Adequacy & RBC Positioning0% complete
Section 1 of 5
Capital Adequacy & RBC Positioning
Evaluates whether your organisation has modelled its capital position under the IA's risk-based methodology: not the legacy solvency margin: and whether the gap between current capital and the RBC minimum has been formally addressed at board level.
Tests against: Capital Shortfall · Pilot Phase Exposure
Question 1
Has your organisation calculated its minimum capital requirement under the IA's risk-based capital methodology: not the legacy SAMA solvency margin: for each material risk category in your health insurance book?
Strong – 3 pointsRBC calculations are complete for all material risk categories (underwriting, market, credit, operational). Results have been reviewed by the board and the gap to the minimum is quantified.
Partial – 2 pointsPreliminary RBC calculations have been run but are incomplete, rely on legacy solvency margin proxies, or have not been reviewed at board level.
Weak – 0 pointsNo RBC calculation has been completed. The organisation does not yet know its capital position under the new methodology.
Question 2
Has the board formally approved a capital plan that closes the gap between the current capital position and the RBC minimum: with a funded timeline that completes before the 2026 pilot begins?
Strong – 3 pointsA board-approved capital plan exists with funded milestones, defined instruments (retained earnings, rights issue, strategic investment), and a completion date before the pilot phase begins.
Partial – 2 pointsA capital plan is under development but has not been formally approved, fully funded, or scheduled against the pilot timeline.
Weak – 0 pointsNo board-approved capital plan. The organisation has not formally addressed the gap between current capital and the RBC minimum.
Question 3
Has your organisation stress-tested its capital position against three adverse scenarios simultaneously: elevated claims inflation, adverse case-mix in the NISS expansion population, and a 15% decline in investment asset valuations?
Strong – 3 pointsAll three adverse scenarios have been modelled simultaneously. Combined impact on the RBC ratio has been quantified and board has set explicit tolerance limits for each scenario.
Partial – 2 pointsIndividual scenarios have been modelled but combined stress has not been analysed, or results have not been translated into board-level tolerance decisions.
Weak – 0 pointsNo combined stress testing. Capital planning is built around the base-case RBC requirement without adverse scenario analysis.
Question 4
Does your board receive a quarterly capital adequacy report that tracks the organisation's position against the projected RBC minimum: with forward-looking projections through to January 2027?
Strong – 3 pointsQuarterly capital reporting to the board includes current RBC ratio, projected trajectory to January 2027, and explicit escalation triggers if the ratio falls below defined thresholds.
Partial – 2 pointsCapital reporting exists but is not structured around the RBC framework, does not include forward projections to 2027, or lacks defined escalation triggers.
Weak – 0 pointsNo RBC-specific capital reporting to the board. Capital adequacy is not being tracked against the new framework on a forward-looking basis.
Question 5
If a merger, acquisition, or strategic capital partnership is under consideration as part of the RBC response, has a structured analytical framework been applied to evaluate counterparty options: including post-merger capital adequacy modelling?
Strong – 3 pointsA structured M&A or strategic partnership evaluation framework is in place, with explicit criteria for counterparty selection, post-merger RBC modelling, and board-approved decision criteria.
Partial – 2 pointsStrategic options are being considered but without a structured analytical framework or post-merger capital modelling.
Weak – 0 pointsNot applicable: organic capital plan only. OR: M&A is being considered without a structured evaluation framework.
Section 2 of 5
Actuarial Repricing & Book Assessment
Tests whether your health insurance pricing models have been rebuilt around risk-based capital requirements and DRG cost weight transitions: not legacy fee-for-service loss ratio experience: and whether loss ratio projections remain valid under the new reimbursement environment.
Tests against: Actuarial Mispricing · Loss Ratio Deterioration
Question 6
Have your health insurance pricing models been rebuilt to reflect AR-DRG cost weights for the specific provider network and beneficiary population in your book: rather than fee-for-service historical loss ratios?
Strong – 3 pointsPricing models have been fully rebuilt on DRG cost weights for the actual beneficiary mix and provider network. Historical FFS loss ratios are used only as a cross-check, not as the primary pricing input.
Partial – 2 pointsDRG cost weight analysis has been conducted but has not been fully integrated into the pricing model. FFS loss ratios remain the primary pricing input with DRG adjustments overlaid.
Weak – 0 pointsPricing models are still based on fee-for-service historical loss ratios. No DRG cost weight repricing has been undertaken.
Question 7
Has the NISS beneficiary expansion been explicitly modelled as an actuarial variable: including adverse selection risk from the 3.2 million new dependent lives entering the insured pool: in your forward loss ratio projections?
Strong – 3 pointsNISS expansion has been modelled explicitly as a demand and case-mix variable in forward loss ratio projections, including adverse selection scenarios for the new dependent population.
Partial – 2 pointsNISS expansion has been noted as a risk factor but has not been quantified or integrated into forward loss ratio projections at the beneficiary segment level.
Weak – 0 pointsNISS expansion has not been incorporated into actuarial modelling. Forward projections are based on the current beneficiary mix.
Question 8
Have you identified which product segments and employer groups in your book are most exposed to loss ratio deterioration under RBC: and have underwriting or pricing adjustments been implemented for those segments?
Strong – 3 pointsSegment-level loss ratio analysis under RBC has been completed. Underwriting criteria or pricing have been adjusted for high-exposure segments, with board awareness of the trade-off between volume and capital efficiency.
Partial – 2 pointsHigh-risk segments have been identified but underwriting or pricing adjustments have not been implemented across the affected book.
Weak – 0 pointsNo segment-level RBC exposure analysis. Underwriting and pricing are not yet calibrated to the risk-based capital implications of the book's composition.
Question 9
Does your actuarial team have the capability to produce, on demand, a capital efficiency report showing the RBC cost of each product segment: enabling the leadership team to make capital allocation decisions across the book?
Strong – 3 pointsCapital efficiency reporting by product segment is available on demand. Leadership uses this analysis to make explicit capital allocation decisions: growing segments with favourable RBC cost and reducing exposure to inefficient segments.
Partial – 2 pointsCapital efficiency analysis can be produced but is not part of routine leadership decision-making. Segment capital costs are understood in principle but not used as an active allocation tool.
Weak – 0 pointsNo capital efficiency reporting. Product and segment decisions are not currently linked to RBC cost implications.
Question 10
Has your organisation modelled the 2027 and 2028 combined ratio projection under three scenarios: base case, medical inflation at 12%, and a 20% increase in inpatient utilisation driven by the NISS expansion?
Strong – 3 pointsAll three scenarios have been modelled for 2027 and 2028. Combined ratio projections under each scenario have been reviewed by the board with explicit decisions on pricing, reserving, and capital buffer requirements.
Partial – 2 pointsSome scenario modelling has been done but does not cover the combined impact of medical inflation and NISS utilisation simultaneously through to 2028.
Weak – 0 pointsNo multi-scenario combined ratio projection. Forward planning is built on base-case assumptions only.
Section 3 of 5
IA Governance & Compliance Remapping
Tests whether your organisation has genuinely remapped its governance and compliance architecture to the Insurance Authority's consolidated framework: not simply updated contact names while preserving the legacy CHI and SAMA operating model.
Has your organisation produced a current, documented map of which regulatory functions have transferred to the IA, which remain transitional, and which new obligations arise from the draft Insurance Law: at the operational level, not just the reporting-line level?
Strong – 3 pointsA detailed operational compliance map has been completed by legal and compliance, reviewed by the board, and translated into updated compliance calendars, filing obligations, and escalation protocols specific to the IA framework.
Partial – 2 pointsA high-level mapping has been done but has not been translated into operational compliance obligations or updated filing calendars for the IA's consolidated framework.
Weak – 0 pointsNo documented compliance map for the IA framework. The organisation is operating on the legacy CHI and SAMA compliance model.
Question 12
Does your board risk committee have explicit visibility of the regulatory concentration risk created by a single regulatory relationship with the IA: and has this been formally incorporated into the enterprise risk register?
Strong – 3 pointsRegulatory concentration risk is formally registered, with an assessed likelihood and impact score reflecting the single-regulator structure. Board risk committee reviews this risk quarterly with defined mitigation actions.
Partial – 2 pointsThe single-regulator structure has been noted as a risk but has not been formally registered, scored, or reviewed with defined mitigation actions at board level.
Weak – 0 pointsNo formal treatment of regulatory concentration risk in the enterprise risk register. The IA consolidation has not changed the risk assessment framework.
Question 13
Is there a named senior executive with explicit accountability for IA relationship management: with direct access to the board and a defined escalation protocol for regulatory engagement above a defined materiality threshold?
Strong – 3 pointsA named C-suite or direct-report executive holds IA relationship accountability, with a defined escalation protocol, board reporting cycle, and authority to engage the IA directly on material matters without operational delays.
Partial – 2 pointsIA relationship management sits at a compliance or legal level but has not been elevated to executive accountability with defined board escalation protocols.
Weak – 0 pointsNo named executive accountability for the IA relationship. Regulatory engagement is handled at a functional level without clear escalation to leadership.
Question 14
Is there a documented process for monitoring IA issuances: circulars, guidelines, and consultations: and translating them into operational compliance obligations within a defined timeframe?
Strong – 3 pointsA formal regulatory monitoring process exists: IA issuances are tracked in real time, assessed for materiality, translated into compliance action plans with defined owners and timelines, and reported to the board risk committee.
Partial – 2 pointsIA issuances are monitored informally by legal or compliance but are not subject to a structured translation process with defined timelines and named owners.
Weak – 0 pointsNo structured IA monitoring process. Regulatory changes are discovered reactively rather than tracked proactively.
Question 15
Has the board received formal legal advice on the implications of the draft Insurance Law: including which provisions will change the organisation's governance obligations, product approvals, or solvency reporting requirements once enacted?
Strong – 3 pointsFormal legal advice on the draft Insurance Law has been provided to the board, with a structured gap analysis against current governance and compliance arrangements and a prioritised action plan for legislative changes expected at enactment.
Partial – 2 pointsLegal analysis of the draft law has been conducted internally but formal external advice with a structured gap analysis has not been obtained or presented to the board.
Weak – 0 pointsNo formal legal analysis of the draft Insurance Law. The organisation has not assessed its governance and compliance implications.
Section 4 of 5
Market Consolidation Strategy
Evaluates whether your organisation has positioned itself analytically for the consolidation dynamic the RBC framework will accelerate: whether as an acquirer, a target, or a firm that retains independence through capital discipline.
Has the board made an explicit strategic decision on the organisation's intended position in the post-RBC market: acquirer, strategic partnership, independent through capital discipline, or willing to consider acquisition: with defined criteria for each path?
Strong – 3 pointsThe board has made an explicit strategic decision on market position, with documented criteria for what would trigger a change of strategy and defined thresholds for each path (capital ratio, market share, loss ratio triggers).
Partial – 2 pointsStrategic options have been discussed at board level but no explicit decision with defined criteria has been made. The organisation's position in the consolidation dynamic is undefined.
Weak – 0 pointsNo board-level strategic discussion on market position in the post-RBC consolidation. The organisation is not yet engaged with the strategic implications of the regulatory change.
Question 17
Has your organisation assessed the RBC adequacy of the insurers with whom you have material reinsurance, network, or partnership arrangements: and does your risk register reflect counterparty exposure to RBC-driven consolidation?
Strong – 3 pointsCounterparty RBC adequacy has been assessed for all material relationships. The risk register includes counterparty capital risk as a rated exposure, with defined triggers for reviewing or restructuring arrangements if a counterparty's capital position deteriorates.
Partial – 2 pointsCounterparty risk is understood at a general level but counterparty RBC adequacy has not been formally assessed or incorporated into the risk register as a specific rated exposure.
Weak – 0 pointsNo counterparty RBC adequacy assessment. The organisation has not analysed how the capital position of its counterparties will affect network and partnership stability.
Question 18
Does your network management function monitor the financial health of key provider counterparties: and have provider contract terms been reviewed for provisions that protect the insurer if a provider faces financial distress during the RBC transition?
Strong – 3 pointsProvider financial health monitoring is active. Key contracts have been reviewed and include provisions for payment deferral, network reassignment, or fee adjustment if a provider's financial position materially deteriorates during the transition.
Partial – 2 pointsProvider financial health is monitored informally. Contract review against transition-period financial risk has not been conducted systematically.
Weak – 0 pointsNo structured provider financial health monitoring. Network contracts have not been reviewed for transition-period financial risk provisions.
Question 19
Has your organisation assessed how the mandatory 30% local reinsurance cession (effective January 2025) affects its reinsurance cost structure and capital efficiency: and has the reinsurance programme been restructured to optimise under both the cession requirement and the RBC framework?
Strong – 3 pointsThe reinsurance programme has been reviewed and restructured to optimise under both the mandatory cession and the RBC framework. Capital relief from reinsurance is explicitly modelled in the RBC calculation.
Partial – 2 pointsThe cession requirement has been complied with but the interaction between the reinsurance structure and the RBC framework has not been formally optimised.
Weak – 0 pointsThe cession has been implemented as a compliance obligation without analysis of its interaction with the RBC capital framework.
Question 20
Does the board have an agreed set of criteria for what would constitute a competitive threat from a post-consolidation larger competitor: and is there an analytical capability to monitor competitor capital adequacy and market share movements as leading indicators?
Strong – 3 pointsBoard-agreed competitive threat criteria are documented, with a market intelligence function that monitors competitor capital filings, market share shifts, and consolidation announcements as structured inputs to strategy reviews.
Partial – 2 pointsCompetitive monitoring occurs but is informal or not structured around RBC-specific indicators. No board-agreed criteria for competitive threat thresholds.
Weak – 0 pointsNo structured competitive monitoring in the context of the RBC consolidation dynamic. Strategy is not actively informed by competitor capital or market share movements.
Section 5 of 5
Pilot Sequencing & January 2027 Readiness
Evaluates whether your organisation is treating the 2026 RBC pilot as a supervised rehearsal under IA observation: and whether the transition to mandatory compliance in January 2027 is planned with sufficient specificity to avoid a last-minute capital or governance crisis.
Tests against: Pilot Underperformance · January 2027 Shock
Question 21
Has your organisation developed a structured 2026 pilot programme: treating the pilot as a supervised rehearsal under IA observation: with defined outputs, governance milestones, and a board review at the midpoint of the pilot year?
Strong – 3 pointsA formal pilot programme plan exists with defined submission timelines, governance milestones, a midyear board review, and an explicit plan for addressing findings from the IA's pilot observations before January 2027.
Partial – 2 pointsThe pilot is understood as an obligation but has not been structured as a rehearsal with defined milestones, board review points, and a post-pilot remediation plan.
Weak – 0 pointsNo formal pilot programme plan. The 2026 pilot is being treated as a data submission exercise rather than a structured rehearsal under regulatory observation.
Question 22
Has the board explicitly approved the maximum capital deviation that is acceptable during the 2026 pilot: and defined the point at which the organisation would seek IA engagement rather than waiting for the regulator to initiate contact?
Strong – 3 pointsBoard-approved deviation thresholds are documented, with a defined protocol for proactive IA engagement if the RBC ratio falls below a specified level during the pilot: before the regulator raises concerns independently.
Partial – 2 pointsCapital deviation thresholds have been discussed but have not been formally approved by the board with a defined proactive engagement protocol.
Weak – 0 pointsNo board-approved deviation thresholds for the pilot year. The organisation will respond to IA contact reactively rather than managing the relationship proactively.
Question 23
Are the data systems, actuarial models, and reporting infrastructure required for RBC submission fully operational and tested against the IA's specified templates and submission requirements: not still in configuration?
Strong – 3 pointsAll systems and models required for RBC submission are operational and have been tested against IA templates. A dry-run submission has been completed internally and results have been reviewed for accuracy and completeness.
Partial – 2 pointsSystems are in advanced configuration but have not been fully tested against IA submission templates. No dry-run has been completed.
Weak – 0 pointsSystems and models for RBC submission are still in early configuration or have not been scoped. The organisation is not operationally ready to submit to the IA.
Question 24
Is there an explicit contingency plan for a scenario where the 2026 pilot reveals a material capital shortfall that cannot be closed before January 2027: including pre-agreed board authority to execute emergency capital actions within a defined timeframe?
Strong – 3 pointsA contingency plan for a material pilot shortfall is documented and board-approved, with pre-agreed authority to execute emergency capital actions (rights issue acceleration, asset disposal, or strategic partnership) within a defined timeframe without requiring a further board meeting.
Partial – 2 pointsContingency options are known but no pre-agreed authority exists. An emergency capital action would require a full board convening, creating a timeline risk if a shortfall is identified late in the pilot year.
Weak – 0 pointsNo contingency plan for a pilot shortfall. The assumption is that the capital plan will be sufficient and no emergency response planning has been done.
Question 25
Has your organisation tested its January 2027 readiness by running a full mock RBC compliance exercise: calculating the mandatory minimum, confirming governance obligations are met, and verifying the submission infrastructure works end-to-end?
Strong – 3 pointsA full mock RBC compliance exercise has been completed, results have been reviewed by the board and external advisors, identified gaps have been addressed, and a final readiness sign-off is scheduled before the January 2027 go-live.
Partial – 2 pointsElements of a mock exercise have been conducted but a full end-to-end readiness test with board review and external validation has not been completed.
Weak – 0 pointsNo mock RBC compliance exercise. The organisation will encounter January 2027 without having tested full end-to-end readiness against the mandatory framework.
IA RBC Transition Readiness Gate – Results
Your RBC Transition Readiness Profile
0
/ 75
Calculating...
Processing your responses...
Domain Breakdown
Capital Adequacy & RBC Positioning
0/15
Actuarial Repricing & Book Assessment
0/15
IA Governance & Compliance Remapping
0/15
Market Consolidation Strategy
0/15
Pilot Sequencing & Jan 2027 Readiness
0/15
Indicative Findings
Calculating...
This self-assessment shows the methodology. The facilitated diagnostic goes further.
A facilitated HealthElevate IA RBC diagnostic includes independent capital gap modelling, actuarial repricing review, IA governance gap analysis, and a board-ready Proceed / Delay / Redesign brief with explicit conditions and a sequenced action plan through January 2027.
Risk-Based Capital and the Insurance Authority: What Saudi Insurers Must Restructure Before 2027
The analytical context behind this instrument: the RBC timeline, consolidation dynamic, and the governance questions the IA will be watching during the 2026 pilot.